Natur Pharma

Latest News for: Natur pharma

MaaT Pharma and Lutech Sign Licensing Agreement on Microbiome Therapy for Graft-vs-Host Disease

Market Watch 21 Jun 2018

The license builds the foundation for MaaT Pharma’s MaaT013 program for which the company recently received authorization from the French regulatory authorities to launch a multicenter Phase 2 study in acute GvHD ... Joel Doré, Research Director at INRA,” said Hervé Affagard, CEO and co-founder of MaaT Pharma ... About MaaT Pharma ... MaaT Pharma"> <Property FormalName="PrimaryTwitterHandle" Value="@MaaT_Pharma....

Edit

These 3 largecaps 2 midcaps can return 11-17% in July series

Moneycontrol 21 Jun 2018

Is it going to be the Nifty Bank index that lifts the Nifty to fresh record highs in the second half of 2018? What is your view on the Nifty Bank index? All pharma and IT counters have rallied big of late ... Buy Sterlite Tech, Dabur, Dishman Pharma ... We were also fortunate to call for a bottom in the Nifty Pharma in the last week of May and that has turned to be quite positive ... Glenmark Pharma ... Sun Pharma....

Edit

Innovus Pharma Receives Approval from Amazon® to Expand its Amazon® Stores to Europe Covering the United Kingdom, France, Germany, Spain and Italy

Market Watch 21 Jun 2018

The additional store will increase the Company’s European presence and help Innovus Pharma’s customers access its products in English, French, German, Spanish and Italian ... Bassam Damaj, the President and Chief Executive Officer of Innovus Pharma ... Innovus Pharma delivers ... Innovus Pharma's Forward-Looking Safe Harbor . ... Innovus Pharma Investor Relations....

Edit

Purdue Pharma axes remaining sales force

Albany Herald-Democrat 21 Jun 2018

Purdue Pharma, the Stamford, Conn., drug maker that designed OxyContin to provide pain relief to millions, said Tuesday it has eliminated its remaining sales force as it shifts to cancer and central nervous disorder medications ... "Purdue Pharma is taking significant steps to transform and diversify beyond our historic focus of pain medications."....

Edit

2018 will be the year of consolidation after stellar gains in 2017: Rakesh Jhunjhunwala

Moneycontrol 21 Jun 2018

Moneycontrol News @moneycontrolcom ... Will political uncertainty impact markets? ... Pharma. "I am pretty sure that worst is behind for pharma sector as generic competition in the US is leveling off," Jhunjhunwala said. He is positive on the domestic branded pharma businesses. "Indian pharma industry is entering unknown, but exciting space.". Healthcare majors Sun Pharma & Lupin entered into speciality generics, the next leg of growth ... ....

Edit

DRAP anomalies

Dawn 21 Jun 2018

The modus operandi is that some pharma firm colludes with DRAP officials who allow the firm a higher retail price on a certain product ... After this, DRAP reduces the price of the same product for all pharma companies in Pakistan, rendering the products unprofitable ... I quote the example of diclofenec sodium tablets ... Shahryar Khan Baseer. Peshawar ... ....

Edit

Market Update: RIL top Nifty gainer, hits new record high; ICICI, Indigo up 1-2%, Infratel down 3%

Yahoo Daily News 21 Jun 2018

Moneycontrol News. The broader indices including the Nifty and the Sensex are trading on a positive note this Thursday morning with the Nifty up 7 points at 10,779 and the Sensex is trading higher by 31 points at 35,578 ... Pharma stocks are also weak in the morning trade dragged by Dr Reddy's Labs, Divis Labs and Aurobindo Pharma ... Disclosure. Reliance Industries Ltd ... ....

Edit

Aditya Birla Sun Life AMC bets on domestic pharma, consumption themes

Moneycontrol 21 Jun 2018

Midcaps’ recent correction, pick up in earnings growth is likely to catch up and it would be a good idea to selectively add them to your portfolio. Moneycontrol News @moneycontrolcom ... Mahesh Patil ... With a slightly long term view, there is scope for a decent upside in earnings growth.”Pharma ... “One could also look at domestic pharma industry, which is in a much better shape.”ConsumptionGoing forward, he sees a pick up in rural consumption....

Edit

Israel's UroGen to start mid-stage bladder cancer trial

This is Money 21 Jun 2018

By Tova Cohen. RAANANA, Israel, June 21 (Reuters) - Israel's UroGen Pharma plans to begin a mid-stage trial of its treatment for bladder cancer patients in August, after positive interim results last month from an advanced trial of a treatment for upper urinary tract cancer ... UroGen's chairman is urologist Arie Belldegrun, who sold cancer therapy company Kite Pharma to Gilead Sciences last year for nearly $12 billion ... Advertisement. ....

Edit

Market Update: RIL top Nifty gainer, hits new record high; ICICI, Indigo up 1-2%, Infratel ...

Moneycontrol 21 Jun 2018

The breadth of the market favoured declines, with 626 stocks advancing, 924 declining and 496 remaining unchanged. On BSE, 829 stocks advanced, 957 declined and 94 remained unchanged. Sandip Das @Im_Sandip1 ... Bank Nifty is flat in the morning trade with ICICI Bank gaining over 1 percent ... related news ... Pharma stocks are also weak in the morning trade dragged by Dr Reddy's Labs, Divis Labs and Aurobindo Pharma ... Reliance Industries Ltd ... ....

Edit

Profit margins of Indian companies at 4-year high

The Times of India 21 Jun 2018

MUMBAI. Profit margins of Indian companies are at a four-year high, raising prospects of a turnaround in corporate earnings ... Underperforming sectors like banks, pharma and cement are also expected to show a turnaround soon ... in the recent past such a phenomenon signalled a change in direction,” Vyas noted ... They forecast that a major part of the growth would come from sectors like corporate banks, cement, pharma and NBFCs ... ....

Edit